Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Clinical trial NCT07480356 · RECRUITING

Trial details

NCT number: NCT07480356
Sponsor: Protara Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder (Urothelial, Transitional Cell) Cancer Non-Muscle Invasive Bladder Carcinoma Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Start date: 2026-05-29
Primary completion: 2028-04-01
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.